A novel multi-epitope recombinant protein elicits an antigen-specific CD8+ T cells response in Trypanosoma cruzi-infected mice
Open Access
- 29 September 2022
- Vol. 40 (45) , 6445-6449
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Characterization and Stability of Trypanosoma cruzi 24-C4 (Tc24-C4), a Candidate Antigen for a Therapeutic Vaccine Against Chagas DiseaseJournal of Pharmaceutical Sciences, 2018
- Multi-epitope vaccines: a promising strategy against tumors and viral infectionsCellular & Molecular Immunology, 2017
- Genetic Adjuvantation of a Cell-Based Therapeutic Vaccine for Amelioration of Chagasic CardiomyopathyInfection and Immunity, 2017
- Cysteine mutagenesis improves the production without abrogating antigenicity of a recombinant protein vaccine candidate for human chagas diseaseHuman Vaccines & Immunotherapeutics, 2016
- Th17 Cells Are More Protective Than Th1 Cells Against the Intracellular Parasite Trypanosoma cruziPLOS Pathogens, 2016
- Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015The Lancet, 2016
- Expression, purification, immunogenicity, and protective efficacy of a recombinant Tc24 antigen as a vaccine against Trypanosoma cruzi infection in miceVaccine, 2015
- From Genome Screening to Creation of Vaccine AgainstTrypanosoma cruziby Use of ImmunoinformaticsThe Journal of Infectious Diseases, 2014
- Effect of a combination DNA vaccine for the prevention and therapy of Trypanosoma cruzi infection in mice: Role of CD4+ and CD8+ T cellsVaccine, 2010
- Modulation of Chagasic Cardiomyopathy by Interleukin-4The American Journal of Pathology, 2001